DrugPatentWatch is published by Yali Friedman, Ph.D.
Dr. Friedman is also publisher of the Journal of Commercial Biotechnology and author of Building Biotechnology, which is used as a course text in dozens of biotechnology programs. He also serves as head of data analytics for Scientific American Custom Media, and was named one of the 100 most influential people in biotechnology by Scientific American.
Dr. Friedman has strong exposure to leading issues in international biotechnology. He is editor of the Scientific American worldVIEW scorecard, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC, in Europe, and throughout Asia.
Marc Teitelbaum is an analyst at DrugPatentWatch
Mr. Teitelbaum is student in the Georgetown University Biotechnology / Biobusiness Master's program. He was also previously a Business Development and Marketing intern at Kashiv Pharma and researched oncology therapeutics at Mt. Sinai Medical Center in New York.
Robert Yapundich, MD, is a practicing neurologist in Hickory, North Carolina and a member of the Alliance for Patient Access and spoke during the Summit.
Gregory Schimizzi, MD, is a practicing rheumatologist, treasurer of the Coalition of State Rheumatology Organizations and co-convener of the Biologics Prescribers Collaborative.